Sign in
Taking people in United StatesNo phase

Home-based program for memory and quality of life after brain cancer

Tests a home-based coaching program in brain tumor survivors and their caregivers.

Key facts

Who runs it
Dartmouth-Hitchcock Medical Center
Where
Lebanon, United StatesSee the site
Trial code
Registry title
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
Status
Recruiting
People taking part
125 people, planned
Started
3 Nov 2025
Expected to end
Dec 2028
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • HOBSCOTCH-CA
Record updated
21 November 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who have survived a primary brain tumor (not glioblastoma) and have memory or thinking problems. A caregiver can also join, but this is optional.

Age
18 years and older.
Sex
All sexes.
Disease stage
A primary brain tumor with expected survival of 2 years or more, such as low-grade glioma, oligodendroglioma, IDH mutant astrocytoma or meningioma. It must be seen on CT or MRI and confirmed by a tissue test. Some people treated for meningioma with radiotherapy may not need the tissue test.
Earlier treatment
Surgery and/or radiation must have ended at least 3 months before joining. People on chemotherapy or other systemic therapy can join. Doses of all medicines acting on the brain and nerves must be stable for one month before joining.

Main reasons for not taking part

  • Glioblastoma (GBM).
  • A disease where brain cells slowly break down, such as Alzheimer's disease or Parkinson's disease.
  • A current serious mental health problem or substance abuse.
  • Not able to read and speak English well.
  • No internet or telephone access for the sessions.

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • 18 + years
  • Service members, Veterans and civilians with a diagnosis of brain cancer (excluding glioblastoma)
  • Diagnosis of primary brain tumor with expected survival of 2 years or greater (e.g., low-grade glioma, oligodendroglioma, IDH mutant astrocytoma, meningioma) defined as the presence of a primary lesion on neuroimaging (CT or MRI), confirmed by histopathological examination (Note: some patients being treated for meningioma may be treated with radiotherapy without need for initial histopathologic confirmation)
  • Patients undergoing surgical and/or radiation therapy will have completed their treatment at least 3 months prior to being enrolled in trial (Note: patients receiving chemotherapy or other systemic therapy will be included)
  • Stable on all CNS acting medications for one month prior to enrollment
  • Subjective cognitive complaints
  • Literate and proficient in English
  • Internet access for the pre-session and Session 1 of the HOBSCOTCH-CA program; telephone access for sessions 2-8
  • Age 18 +
  • Caregiver to a patient with a confirmed diagnosis of brain cancer/tumor survivor
  • CA Subject has given permission for their caregiver to participate
  • Literate and proficient in English
  • Internet access (for Pre-HOBSCOTCH and Session 1)
  • Telephone access (for Session 8)

Who cannot take part

  • Presence of a neurodegenerative disease (e.g., Alzheimer's disease, Parkinson's disease)
  • Acute psychiatric disorder or substance abuse
  • Significant visual impairment precluding reading or writing
  • Patients with glioblastoma (GBM)
  • No reliable telephone or internet access

Other criteria

  • CA Participants will be referred to the study by their providers (Oncologist) who will be made aware of the study and inclusion/exclusion criteria. Inclusion Criteria 2. - 5. and Exclusion Criteria 1. - 3. will be confirmed by referring providers. Participants who learn about the study here and elsewhere will be instructed on how to confirm their eligibility with their provider

This trial is currently available in United States.

  • Dartmouth-Health LebanonLebanon, United StatesContact: Kathryn GiordanoTaking people

About the trial

What the trial wants to find out

The purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-CA, to improve the quality of life and cognitive function in Service Members, Veterans and civilians who are survivors of brain cancer or a brain tumor (CA participants). This study will also assess the ability of the HOBSCOTCH-CA program to improve quality of life in caregivers of patients with brain cancer/tumor and to reduce caregiver burden. Enrolling with a Caregiver is optional for CA participants.

Read full original descriptionShow less

Investigators will compare two groups of CA participants and their Caregiver (enrolling with a Caregiver is optional): one who receives HOBSCOCTCH-CA immediately (Group 1) and another group that will receive HOBSCOTCH-CA (Group 2) after a 3-month waiting period. Participants will be in the study for about 6 months total.

HOBSCOTCH-CA involves 45 to 60 minute one on one virtual sessions with a certified Cognitive Coach including a "pre" program session and 8 weekly sessions thereafter. Participants will learn about problem solving therapy and mindfulness or relaxation training. CA participants are asked to do short homework assignments and keep a brief daily diary on a smart phone app. All participants complete study questionnaires or surveys at enrollment, 3 months later and at 6 months (at the end of the study).

The 4 groups in the trial

  • CA Participant-Group 1Treatment being tested

    After enrollment and completion of baseline assessments, CA Participant Group 1 will receive the HOBSCOTCH-PTE intervention consisting of 1:1 sessions delivered once per week including: * 1 pre-HOBSCOTCH Session (on webcam) * 1 educational session (on webcam) * 6 telephone sessions (option to do on webcam) * 1 wrap-up session (webcam or telephone)

    Treatment: HOBSCOTCH-CA

  • CA Participant-Group 2Existing treatment, for comparison

    After a 3-month waiting period and having completed baseline and 3-month study assessments, CA Participant Group 2 will receive the HOBSCOTCH-CA intervention consisting of 1:1 sessions delivered once per week including: * 1 pre-HOBSCOTCH Session (on webcam) * 1 educational session (on webcam) * 6 telephone sessions (option to do on webcam) * 1 wrap-up session (webcam or telephone)

    Treatment: HOBSCOTCH-CA

  • CA Participant Caregiver-Group 1Treatment being tested

    After enrollment and completion of baseline assessments, CA Participant Caregiver Group 1 will receive an adapted version of HOBSCOTCH-CA alongside the CA participant by attending: * 1 pre-HOBSCOTCH Session (on webcam) * 1 educational session (on webcam) * 1 wrap-up session (webcam or telephone)

    Treatment: HOBSCOTCH-CA

  • CA Participant Caregiver-Group 2Existing treatment, for comparison

    After a 3-month waiting period and having completed baseline and 3-month study assessments, CA Participant Caregiver Group 2 will receive an adapted version of HOBSCOTCH-CA alongside the CA participant by attending: * 1 pre-HOBSCOTCH Session (on webcam) * 1 educational session (on webcam) * 1 wrap-up session (webcam or telephone)

    Treatment: HOBSCOTCH-CA

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
Plain-language title
Home-based program for memory and quality of life after brain cancerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
21 November 2025